Curdlan is a natural β-1, 3-glucan produced byAgrobacterium biovar 1. In this study, the anticoagulant activity of sulfoalkyl derivatives of curdlan was investigated by carrying out activated partial thromboplastin time (APTT) assay and compared with that ofo-sulfonated curdlan. Approximately 100-fold higher concentration ofo-sulfonated curdlan than heparin was required to obtain the same level of the clotting time. Anticoagulant activity of curdlan derivatives was dependent on the degree of sulfation in prolonging the clotting time. However, the chain length of the substituent did not play a role in prolonging the clotting time. The curdlan derivatives enhanced thrombin inhibition by mediating through antithrombin III. The inhibition of thrombin byo-sulfonated curdlan was found to be approximately 10-fold weaker than that by heparin.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Alban, S., Jeske, W., Welzel, D., Franz, G. and Fareed J., Antocoagulant and antithombotic actions of a semisynthetic β1, 3-glucan sulfate.Thromb. Res., 78, 201–210 (1995).
Casu B., Grazioli G., Razi N., Guerrini M., Naggi A., Torri G., Oreste, P., Tursi F, Zoppetti G. and Lindahl U., Heparin-like compounds prepared by chemical modification of capsular polysaccharide fromE. coli. K5.Carbohydr. Res., 263, 271–284 (1994).
Demleitner, S., Kraus, J. and Franz, G., Synthesis and antitumor activity of sulfoalkyl derivatives of curdlan and lichenan.Carbohydr. Res., 26, 247–252 (1992).
Farias, W. R. L., Valente, A. P., Pereira, M. S. and Mourao, P. A. S., Structure and anticoagulant activity of sulfated galactans.J. Biol. Chem., 275, 29299–29307 (2000).
Franz, G. and Alban, S., Structure-activity relationship of antithrombotic polysaccharide derivatives.Int. J. Biol. Macromol., 17, 311–314 (1995).
Gao, Y., Fukuda, A., Katsuraya, K., Kaneko, Y., Mimura, T., Nakashima, H. and Uryu, T., Synthesis of regioselective substituted curdlan sulfates with medium molecular weights and their specific anti HIV-1 activities.Macromol., 30, 3224–3228 (1997).
Harada, T., Misaka, A. and Satio, H., Curdlan: a bacterial gel forming β-1, 3-glucan.Arch. Biochem. Biophys., 124, 292–298 (1968).
Kim, B. S., Jung, I. D., Kim, J. S., Lee, J. H., Lee, I. Y. and Lee, K. B., Curdlan gels as protein drug delivery vehicles.Biotech. Lett., 22, 1127–1130 (2000).
Kurachi, K., Ohno, N. and Yadomae, T., Preparation and antitumor activity of hydroxyethylated derivatives of 6-branched (1-3)-β-D-glucan, SSG, obtained from the culture filtrate ofSclerotinia sclerotiorum IFO 9395.Chem. Pharm. Bull., 38, 2527–2531 (1990).
Lee, K. B., Kim, J. S., Yoo, Y. C., Kwak, S. T., Song, K. S. and Kim, Y. S., Isolation and characterization of proteoglycan derived from human placenta and its biological activities.Arch. Pharm. Res., 23, 182–186 (2000).
Maaroufi, R. M., Tapon-Bretaudiere J., Mardiguian J. and Sternberg C., Dautzenberg M. D. Fischer A. M., Influence of the oversulfation method and the degree of sulfation on the anticoagulant properties of dermatan sulfate derivatives.Thromb. Res., 59, 749–758 (1990).
Usui, S., Matsunaga, T., Ukai, S. and Kiho, T., Growth suppressing activity for endothelial cells induced from macrophages by carboxymethylated curdlan.Biosci. Biotech. Biochem., 61, 1924–1925 (1997).
Wu, S. J., Chun, M. W., Shin, K. H., Toida, T., Park, Y., Linhardt, R. J., Kim, Y. S., Chemical sulfonation and anticoagulant activity of acharan sulfate.Thromb. Res., 92, 273–281 (1998).
Yoshida, T., Yasuda, Y., Mimura, T. Y., Kaneko, Y., Nakashima, H., Yamamoto, N. and Uryu, T., Synthesis of curdlan sulfates having inhibitory effects in vitro against AIDS viruses HIV-1 and HIV-2.Carbohydr. Res., 276, 425–436 (1995).
Zhang, L., Zhang, M., Zhou, Q., Chen, J. and Zeng, F., Solution properties of antitumor sulfated derivative of alpha-(1→3)-D-glucan fromGanoderma lucidum.Biosci. Biotechnol. Biochem., 64, 2172–8 (2000).
About this article
Cite this article
Lee, K.B., Bae, J.H., Kim, J.S. et al. Anticoagulant activity of sulfoalkyl derivatives of curdlan. Arch. Pharm. Res. 24, 109 (2001). https://doi.org/10.1007/BF02976477
- Anticoagulant activity
- Sulfoalkyl derivatives
- Activated partial thromboplastin time